Current Opinion in Urology

Papers
(The H4-Index of Current Opinion in Urology is 15. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Editorial introductions69
Endemic statistical paradoxes in epidemiologic studies distort knowledge on prostate cancer: mitigation and caution of fallacies in prostate cancer causal epidemiological studies47
Research frontiers in urology45
Prognostic impact of serum testosterone in metastatic hormone-naive prostate cancer: a systematic review and meta-analysis43
Immunotherapy combinations for metastatic castration-resistant prostate cancer – failed trials and future aspects25
Exploring the impact of artificial intelligence–enabled decision aids in improving patient inclusivity, empowerment, and education in urology: a systematic review by EAU endourology23
Lithotripsy devices for percutaneous nephrolithotomy (PNL) – new developments21
Minimizing overtreatment and maximizing oncologic outcomes in upper tract urothelial carcinoma21
Device-assisted intravesical chemotherapy treatment for nonmuscle invasive bladder cancer: 2022 update19
The role of innovations in advancing urologic oncologic patient care18
Tumor-informed circulating tumor DNA in urothelial carcinoma: a promising novel biomarker18
Editorial introductions17
Molecular biomarkers to help select neoadjuvant systemic therapy for urothelial carcinoma of the bladder17
RNA-based urinary assays for non-muscle invasive bladder cancer16
Editorial introductions16
Systemic immunotherapy for BCG unresponsive nonmuscle-invasive bladder cancer15
Testicular cancer with small metastatic burden: optimal approach in 202415
Editorial introductions15
0.25800108909607